Cargando…

Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen

INTRODUCTION: Lateral flow assay is an advanced method useful in the early diagnosis of cryptococcal meningitis. We aimed to compare two commercial tests for cryptococcal capsular antigen in the sera of asymptomatic patients with human immunodeficiency virus in Barranquilla, Colombia. METHODS: Thawe...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguera, María Clara, Escandón, Patricia, Rodríguez, Javier, Parody, Alexander, Camargo, Leidy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Medicina Tropical - SBMT 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437440/
https://www.ncbi.nlm.nih.gov/pubmed/34495257
http://dx.doi.org/10.1590/0037-8682-0307-2021
_version_ 1783752168773255168
author Noguera, María Clara
Escandón, Patricia
Rodríguez, Javier
Parody, Alexander
Camargo, Leidy
author_facet Noguera, María Clara
Escandón, Patricia
Rodríguez, Javier
Parody, Alexander
Camargo, Leidy
author_sort Noguera, María Clara
collection PubMed
description INTRODUCTION: Lateral flow assay is an advanced method useful in the early diagnosis of cryptococcal meningitis. We aimed to compare two commercial tests for cryptococcal capsular antigen in the sera of asymptomatic patients with human immunodeficiency virus in Barranquilla, Colombia. METHODS: Thawed (n=162) previously collected serums (2016-2019) were processed using IMMY and Dynamiker cryptococcal antigen lateral flow assay. RESULTS: Compared to IMMY’s results, Dynamiker’s sensitivity, specificity, positive predictive value, negative predictive value, and kappa index were 100%, 89.9%, 48.3%, 100.0%, and 0.61, respectively. CONCLUSIONS: The Dynamiker test had excellent sensitivity, acceptable specificity, and a low detection threshold for cryptococcal antigen in the tested samples.
format Online
Article
Text
id pubmed-8437440
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Medicina Tropical - SBMT
record_format MEDLINE/PubMed
spelling pubmed-84374402021-09-20 Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen Noguera, María Clara Escandón, Patricia Rodríguez, Javier Parody, Alexander Camargo, Leidy Rev Soc Bras Med Trop Short Communication INTRODUCTION: Lateral flow assay is an advanced method useful in the early diagnosis of cryptococcal meningitis. We aimed to compare two commercial tests for cryptococcal capsular antigen in the sera of asymptomatic patients with human immunodeficiency virus in Barranquilla, Colombia. METHODS: Thawed (n=162) previously collected serums (2016-2019) were processed using IMMY and Dynamiker cryptococcal antigen lateral flow assay. RESULTS: Compared to IMMY’s results, Dynamiker’s sensitivity, specificity, positive predictive value, negative predictive value, and kappa index were 100%, 89.9%, 48.3%, 100.0%, and 0.61, respectively. CONCLUSIONS: The Dynamiker test had excellent sensitivity, acceptable specificity, and a low detection threshold for cryptococcal antigen in the tested samples. Sociedade Brasileira de Medicina Tropical - SBMT 2021-09-06 /pmc/articles/PMC8437440/ /pubmed/34495257 http://dx.doi.org/10.1590/0037-8682-0307-2021 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Short Communication
Noguera, María Clara
Escandón, Patricia
Rodríguez, Javier
Parody, Alexander
Camargo, Leidy
Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
title Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
title_full Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
title_fullStr Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
title_full_unstemmed Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
title_short Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
title_sort comparison of two commercial tests (immy vs. dynamiker) for cryptococcal capsular antigen
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437440/
https://www.ncbi.nlm.nih.gov/pubmed/34495257
http://dx.doi.org/10.1590/0037-8682-0307-2021
work_keys_str_mv AT nogueramariaclara comparisonoftwocommercialtestsimmyvsdynamikerforcryptococcalcapsularantigen
AT escandonpatricia comparisonoftwocommercialtestsimmyvsdynamikerforcryptococcalcapsularantigen
AT rodriguezjavier comparisonoftwocommercialtestsimmyvsdynamikerforcryptococcalcapsularantigen
AT parodyalexander comparisonoftwocommercialtestsimmyvsdynamikerforcryptococcalcapsularantigen
AT camargoleidy comparisonoftwocommercialtestsimmyvsdynamikerforcryptococcalcapsularantigen